Annual report
3733.TEDINET S100SO5Z
Period2022-11-01 → 2023-10-31
Filed2024-01-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amended by S100V0JJ (2024-12-25).
Key figures · 138
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥33.7bn | 2022-11-01 → 2023-10-31 | Cons. | Net sales |
| Revenue | ¥27.6bn | 2021-11-01 → 2022-10-31 | Cons. | Net sales |
| Revenue | ¥25.3bn | 2020-11-01 → 2021-10-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥20.5bn | 2019-11-01 → 2020-10-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥6.5bn | 2022-11-01 → 2023-10-31 | Cons. | Operating income |
| Operating income | ¥4.9bn | 2021-11-01 → 2022-10-31 | Cons. | Operating income |
| Ordinary income | ¥6.6bn | 2022-11-01 → 2023-10-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.9bn | 2021-11-01 → 2022-10-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.3bn | 2020-11-01 → 2021-10-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.4bn | 2019-11-01 → 2020-10-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥6.6bn | 2022-11-01 → 2023-10-31 | Cons. | Income before income taxes |
| Profit before tax | ¥4.9bn | 2021-11-01 → 2022-10-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥4.9bn | 2022-11-01 → 2023-10-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.4bn | 2021-11-01 → 2022-10-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.0bn | 2020-11-01 → 2021-10-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.3bn | 2019-11-01 → 2020-10-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥4.9bn | 2022-11-01 → 2023-10-31 | Cons. | Profit loss |
| Net income | ¥3.4bn | 2021-11-01 → 2022-10-31 | Cons. | Profit loss |
| Total assets | ¥39.9bn | at 2023-10-31 | Cons. | Assets |
| Total assets | ¥33.7bn | at 2022-10-31 | Cons. | Assets |
| Total assets | ¥31.6bn | at 2021-10-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥27.4bn | at 2020-10-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.3bn | at 2023-10-31 | Cons. | Liabilities |
| Total liabilities | ¥6.5bn | at 2022-10-31 | Cons. | Liabilities |
| Net assets / equity | ¥31.6bn | at 2023-10-31 | Cons. | Net assets |
| Net assets / equity | ¥27.3bn | at 2022-10-31 | Cons. | Net assets |
| Net assets / equity | ¥25.8bn | at 2021-10-31d | Cons. | Net assets |
| Net assets / equity | ¥23.2bn | at 2020-10-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.8bn | at 2023-10-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.2bn | at 2022-10-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.7bn | at 2023-10-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.1bn | at 2022-10-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.1bn | at 2021-10-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.4bn | at 2020-10-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥5.6bn | 2022-11-01 → 2023-10-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.3bn | 2021-11-01 → 2022-10-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.4bn | 2020-11-01 → 2021-10-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.5bn | 2019-11-01 → 2020-10-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥637m | 2022-11-01 → 2023-10-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.4bn | 2021-11-01 → 2022-10-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.1bn | 2020-11-01 → 2021-10-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥112m | 2019-11-01 → 2020-10-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥624m | 2022-11-01 → 2023-10-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.9bn | 2021-11-01 → 2022-10-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥533m | 2020-11-01 → 2021-10-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥489m | 2019-11-01 → 2020-10-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥930.35 | 2022-11-01 → 2023-10-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥628.54 | 2021-11-01 → 2022-10-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥551.8 | 2020-11-01 → 2021-10-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥431.67 | 2019-11-01 → 2020-10-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥6,052.69 | at 2023-10-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥5,214.02 | at 2022-10-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,751.95 | at 2021-10-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,272.7 | at 2020-10-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 79.3% | at 2023-10-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.8% | at 2022-10-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.7% | at 2021-10-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.9% | at 2020-10-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 16.5% | 2022-11-01 → 2023-10-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.8% | 2021-11-01 → 2022-10-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.2% | 2020-11-01 → 2021-10-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.1% | 2019-11-01 → 2020-10-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,640 | at 2023-10-31 | Cons. | Number of employees |
| Employees | 1,623 | at 2022-10-31 | Cons. | Number of employees |
| Employees | 1,579 | at 2021-10-31d | Cons. | Number of employees |
| Employees | 1,472 | at 2020-10-31d | Cons. | Number of employees |
| Revenue | ¥32.5bn | 2022-11-01 → 2023-10-31 | Standalone | Net sales |
| Revenue | ¥26.2bn | 2021-11-01 → 2022-10-31 | Standalone | Net sales |
| Revenue | ¥24.2bn | 2020-11-01 → 2021-10-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥20.5bn | 2019-11-01 → 2020-10-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥22.4bn | 2018-11-01 → 2019-10-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥6.3bn | 2022-11-01 → 2023-10-31 | Standalone | Operating income |
| Operating income | ¥4.6bn | 2021-11-01 → 2022-10-31 | Standalone | Operating income |
| Ordinary income | ¥6.3bn | 2022-11-01 → 2023-10-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.7bn | 2021-11-01 → 2022-10-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.2bn | 2020-11-01 → 2021-10-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.4bn | 2019-11-01 → 2020-10-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.9bn | 2018-11-01 → 2019-10-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥6.3bn | 2022-11-01 → 2023-10-31 | Standalone | Income before income taxes |
| Profit before tax | ¥4.7bn | 2021-11-01 → 2022-10-31 | Standalone | Income before income taxes |
| Net income | ¥4.7bn | 2022-11-01 → 2023-10-31 | Standalone | Profit loss |
| Net income | ¥3.3bn | 2021-11-01 → 2022-10-31 | Standalone | Profit loss |
| Net income | ¥2.9bn | 2020-11-01 → 2021-10-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.4bn | 2019-11-01 → 2020-10-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.7bn | 2018-11-01 → 2019-10-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥39.1bn | at 2023-10-31 | Standalone | Assets |
| Total assets | ¥33.2bn | at 2022-10-31 | Standalone | Assets |
| Total assets | ¥31.0bn | at 2021-10-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥26.9bn | at 2020-10-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥25.3bn | at 2019-10-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥7.9bn | at 2023-10-31 | Standalone | Liabilities |
| Total liabilities | ¥6.2bn | at 2022-10-31 | Standalone | Liabilities |
| Net assets / equity | ¥31.2bn | at 2023-10-31 | Standalone | Net assets |
| Net assets / equity | ¥27.0bn | at 2022-10-31 | Standalone | Net assets |
| Net assets / equity | ¥25.7bn | at 2021-10-31d | Standalone | Net assets |
| Net assets / equity | ¥23.2bn | at 2020-10-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥21.4bn | at 2019-10-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥10.3bn | at 2023-10-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.8bn | at 2022-10-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥4.5bn | at 2019-10-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥3.0bn | 2018-11-01 → 2019-10-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥7.2bn | 2018-11-01 → 2019-10-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥679m | 2018-11-01 → 2019-10-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥899.79 | 2022-11-01 → 2023-10-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥602.1 | 2021-11-01 → 2022-10-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥530.07 | 2020-11-01 → 2021-10-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥433.1 | 2019-11-01 → 2020-10-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥496.66 | 2018-11-01 → 2019-10-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥120 | 2022-11-01 → 2023-10-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥100 | 2021-11-01 → 2022-10-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥95 | 2020-11-01 → 2021-10-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥85 | 2019-11-01 → 2020-10-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2018-11-01 → 2019-10-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥5,971.31 | at 2023-10-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥5,165.14 | at 2022-10-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥4,729.53 | at 2021-10-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥4,274.13 | at 2020-10-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,928.62 | at 2019-10-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 79.8% | at 2023-10-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.4% | at 2022-10-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.9% | at 2021-10-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.2% | at 2020-10-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.4% | at 2019-10-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 16.2% | 2022-11-01 → 2023-10-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.4% | 2021-11-01 → 2022-10-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.8% | 2020-11-01 → 2021-10-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.6% | 2019-11-01 → 2020-10-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.3% | 2018-11-01 → 2019-10-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 5,488,000 | at 2023-10-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,488,000 | at 2022-10-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,488,000 | at 2021-10-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,488,000 | at 2020-10-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,488,000 | at 2019-10-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,589 | at 2023-10-31 | Standalone | Number of employees |
| Employees | 1,570 | at 2022-10-31 | Standalone | Number of employees |
| Employees | 1,534 | at 2021-10-31d | Standalone | Number of employees |
| Employees | 1,424 | at 2020-10-31d | Standalone | Number of employees |
| Employees | 1,325 | at 2019-10-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 1
| Segment | Item | Period | Value |
|---|---|---|---|
| Electric Medical Record System Businessreportable segment | employees | at 2023-10-31 | 1640 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,175
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration_NonConsolidatedMember | － | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration_NonConsolidatedMember | -678804000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration_NonConsolidatedMember | － | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration_NonConsolidatedMember | － | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration_NonConsolidatedMember | － | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 4482592000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant_NonConsolidatedMember | － | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant_NonConsolidatedMember | － | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant_NonConsolidatedMember | － | JPY |
| Cash and cash equivalents (5-year summary) | CurrentYearInstant_NonConsolidatedMember | － | JPY |
| Number of employees | Prior4YearInstant_NonConsolidatedMember | 1325 | |
| Number of employees | Prior3YearInstant_NonConsolidatedMember | 1424 | |
| Number of employees | Prior2YearInstant_NonConsolidatedMember | 1534 | |
| Number of employees | Prior1YearInstant_NonConsolidatedMember | 1570 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 1589 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | 1.382 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 1.341 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 0.878 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 1.012 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 1.069 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 1.039 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 1.008 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.304 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.291 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.547 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E05376-000ElectricMedicalRecordSystemBusinessReportableSegmentMember | 1640 | |
| Number of employees | CurrentYearInstant | 1640 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 1589 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 32.65 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 8.32 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 5374000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration | 546000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 194000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 5488000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 5488000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 5488000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 5488000 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 6 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 20 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 19 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 87 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 3 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 1915 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 2050 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 1522 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |